Results 1 to 10 of about 75,012 (195)

The effects of glucagon-like peptide-1 receptor agonists on sympathetic neuron activity. [PDF]

Hypertens Res
Koyanagi Y, Iigaya K, Ikeda K, Onimaru H, Izumizaki M.   +4 more
europepmc   +1 more source

Signaling architecture of the glucagon-like peptide-1 receptor. [PDF]

J Clin Invest
Austin G, Tomas A.
europepmc   +1 more source

Glucagon-like peptide-1 receptor agonists for heart failure with reduced ejection fraction: Is it the next step? [PDF]

ESC Heart Fail
Biegus J.
europepmc   +1 more source

Administrative costs of prior authorizations for glucagon-like peptide-1 agonists. [PDF]

J Manag Care Spec Pharm
Pham D, Duby JJ, Setoudeh S, Knox S, Leahy K, Cruz D, Cutler T.   +6 more
europepmc   +1 more source

Glucagon-like Peptide-1 Receptor Agonists and Colorectal Cancer Risk. [PDF]

AACE Endocrinol Diabetes
Winkelman JW, Levine MJ.
europepmc   +1 more source

Immediate allergy against glucagon-like peptide-1 receptor agonist liraglutide. [PDF]

Asia Pac Allergy
Özdemir Ö.
europepmc   +1 more source

Oral Glucagon-Like Peptide-1 Receptor Agonists for Preventing Cardiorenal Complications. [PDF]

Curr Cardiol Rep
Odeleye V, Singh N, Gautam S, Shannon E, Bibb WM, McClure M, Paul TK.   +6 more
europepmc   +1 more source

Beyond Glycemic Control: Ocular Effects of Glucagon-like Peptide-1 Receptor Agonists. [PDF]

Vision (Basel)
Lixi F, Troisi M, Calabresi V, Giagoni A, Rossi C, Timofte-Zorila MM, Tarași TC, Vitiello L, Tomi MI, Gheorghe AG, Coco G, Lanzolla G, Giannaccare G.   +12 more
europepmc   +1 more source

Cohort Study: Risk of Gallstones and Biliary Complications With Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes. [PDF]

United European Gastroenterol J
Eldesouki MH, Alkasabrah O, Kloub M, Abosheaishaa H, Elfert K, Sharma A, Andrawes S, Duong N.   +7 more
europepmc   +1 more source

Glucagon-like peptide-1 receptor agonists in patients with heart failure with reduced ejection fraction. [PDF]

ESC Heart Fail
Kassab J, Drazner MH, Thibodeau JT.
europepmc   +1 more source